"Health policymakers should recognise that the patient experience and healthcare needs of people with multimorbidity are likely to be different to those with a single long-term condition, and should take this into account when designing health services for people with multiple long-term conditions. We recommend that research modelling the relationship between multimorbidity and patient experience of care should include the impact of health-related quality of life."
Why do patients with multimorbidity in England report worse experiences in primary care? Evidence from the General Practice Patient Survey
CAM Paddison, CL Saunders, GA Abel, RA Payne, JL Campbell, M Roland
BMJ Open, 2015, 5:e006172
Read more here.
QIPP stands for Quality, Innovation, Productivity and Prevention. The aim of this initiative is to help health care organisations deliver higher quality care and operate more efficiently and effectively.
Showing posts with label policymakers. Show all posts
Showing posts with label policymakers. Show all posts
Friday, 1 May 2015
Why do patients with multimorbidity in England report worse experiences in primary care?
Labels:
general practice,
multimorbidity,
patient experience,
policymakers,
primary care,
quality of life,
service design
Saturday, 31 May 2014
Health inequalities in European cities
"More funding should be put towards academic research on effective universal policies, evaluation of their impact and training policymakers and officers on health inequalities in city governments."
Health inequalities in European cities: perceptions and beliefs among local policymakers
J Morrison, et al
BMJ Open, 2014, 4:e004454
Read more here.
Health inequalities in European cities: perceptions and beliefs among local policymakers
J Morrison, et al
BMJ Open, 2014, 4:e004454
Read more here.
Labels:
disadvantaged,
Europe,
health disparaties,
health inequalities,
policymakers,
social inequalities,
variation
Monday, 5 May 2014
Healing medical product innovation
"To spur inventors to create medical products that lower health care spending and promote health, policymakers need to address the perverse financial incentives that lead inventors and investors in the opposite direction."
Healing medical product innovation
S Garber, SM Gates, EB Keeler, ME Vaiana, AW Mulcahy, C Lau, AL Kellerman
RAND Corporation
2014
Read more here.
Healing medical product innovation
S Garber, SM Gates, EB Keeler, ME Vaiana, AW Mulcahy, C Lau, AL Kellerman
RAND Corporation
2014
Read more here.
Labels:
cost,
improvement,
innovation,
policymakers,
spending,
value
Subscribe to:
Posts (Atom)